| Q34711999 | Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero |
| Q34041955 | Affordable, abbreviated roche monitor assay for quantification of human immunodeficiency virus type 1 RNA in plasma |
| Q35682303 | Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis |
| Q44098419 | Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. |
| Q34608508 | Antibody maturation and viral diversification in HIV-infected women |
| Q40284630 | Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women |
| Q33648264 | Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. |
| Q38801873 | Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057. |
| Q36279151 | Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009. |
| Q46937504 | Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. |
| Q38292257 | Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants |
| Q34549627 | Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants |
| Q35043592 | Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial |
| Q46902925 | Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1. |
| Q39361514 | Diagnosis of female genital schistosomiasis by indirect disease markers: determination of eosinophil cationic protein, neopterin and IgA in vaginal fluid and swab eluates. |
| Q36606419 | Distribution of haematological and chemical pathology values among infants in Malawi and Uganda |
| Q43937444 | Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants |
| Q43518589 | Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens. |
| Q44829214 | Effect of antibiotic treatment of subclinical mastitis on human immunodeficiency virus type 1 RNA in human milk. |
| Q35452458 | Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi |
| Q37705259 | Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). |
| Q57207561 | Epidemiology and microbiology of subclinical mastitis among HIV-infected women in Malawi |
| Q36174430 | Evaluation of postpartum HIV superinfection and mother-to-child transmission |
| Q46558677 | Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission |
| Q57980664 | Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings |
| Q46484097 | Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi. |
| Q48290657 | Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study |
| Q43257966 | Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi |
| Q46152471 | Gender differences in perinatal HIV acquisition among African infants |
| Q57207552 | HIV Incidence Among Women of Reproductive Age in Malawi and Zimbabwe |
| Q46913975 | HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi |
| Q45273875 | Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth |
| Q37009811 | Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load |
| Q44010684 | Higher in utero and perinatal HIV infection risk in girls than boys |
| Q45749168 | Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. |
| Q45731622 | Human immunodeficiency virus type 1 infection in twin pairs infected at birth. |
| Q43698107 | Impact of vitamin A supplementation on anaemia and plasma erythropoietin concentrations in pregnant women: a controlled clinical trial. |
| Q34756810 | Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants |
| Q33275194 | Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial |
| Q45737667 | Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi |
| Q46816781 | Late postnatal transmission of HIV-1 and associated factors |
| Q39312681 | Malaria and human immunodeficiency virus infection among male employees of a sugar estate in Malawi |
| Q36581681 | Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009. |
| Q35062018 | Methods for assessing quality of provider performance in developing countries |
| Q33872160 | Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. |
| Q45955573 | Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. |
| Q38880827 | Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. |
| Q44975158 | Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial |
| Q45172170 | Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa |
| Q37551251 | Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life |
| Q30569674 | Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission |
| Q44208352 | Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial |
| Q43260833 | Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy |
| Q39094740 | Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. |
| Q38879379 | Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. |
| Q46181807 | Resumption of sexual activity and regular menses after childbirth among women infected with HIV in Malawi |
| Q39397558 | Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report. |
| Q57207567 | Safety, Acceptability, and Potential Efficacy of a Topical Penile Microbicide Wipe |
| Q35790256 | Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. |
| Q35780244 | Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi |
| Q57207542 | Short Communication: HIV Type 1 Variants with Nevirapine Resistance Mutations Are Rarely Detected in Antiretroviral Drug-Naive African Women with Subtypes A, C, and D |
| Q44625140 | Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial |
| Q36113222 | Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants |
| Q57207520 | The Effect of Human Immunodeficiency Virus and Breastfeeding on the Nutritional Status of African Children |
| Q37063553 | The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa |
| Q45721890 | The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa |
| Q45369760 | The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis |
| Q36433157 | The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns |
| Q37425296 | Training for health services and systems research in Sub-Saharan Africa--a case study at four East and Southern African universities |
| Q35897529 | Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi |
| Q39460463 | Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. |
| Q45451237 | Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa |
| Q57207576 | Viral levels in newborn African infants undergoing primary HIV-1 infection |
| Q45746366 | Virus levels in untreated African infants infected with human immunodeficiency virus type 1. |
| Q45795834 | Vitamin D levels in Malawian infants from birth to 24 months |